½É¹æ¼¼µ¿ ½ÃÀå : À¯Çüº°, Ä¡·á¹ýº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Atrial Fibrillation Market, By Type, By Treatment, By Technology, By End User, By Geography
»óǰÄÚµå
:
1671852
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
½É¹æ¼¼µ¿ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 264¾ï 3,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 7.4%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 435¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§
º¸°í¼ »ó¼¼
±âÁØ ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
264¾ï 3,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR
7.40%
2032³â °¡Ä¡ ¿¹Ãø
435¾ï 7,000¸¸ ´Þ·¯
±×¸². ½É¹æ¼¼µ¿ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
½É¹æ¼¼µ¿Àº Àü ¼¼°èÀûÀ¸·Î °¡Àå ÈçÇÑ ºÎÁ¤¸ÆÀ̸ç, Áø´Ü »ç·ÊÀÇ À¯º´·üÀÌ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸ÀÇ Áõ°¡, ½ÉÇ÷°üÁúȯ ¹× »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡, ħ½ÀÀû ½ÉÀå ¼ö¼úÀÇ Áõ°¡, Áø´Ü ¹× Ä¡·á ±â±âÀÇ ±â¼ú ¹ßÀüÀº ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ±×·¯³ª ½É¹æ¼¼µ¿ Áø´Ü ¹× Ä¡·á¿¡ µû¸¥ Ç÷Àü»öÀüÁõ À§Çè°ú °³¹ßµµ»ó±¹ÀÇ ½É¹æ¼¼µ¿¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¿ªÇÐ:
¼¼°è ½É¹æ¼¼µ¿ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ½É¹æ¼¼µ¿ Ãë¾à ³ëÀÎ Àα¸ÀÇ ±ÞÁõ, ºñ¸¸ ¹× °íÇ÷¾Ð À¯º´·ü Áõ°¡, ¾ËÄÚ¿Ã ¹× ´ã¹è ¼Òºñ Áõ°¡, ħ½ÀÀû ½ÉÀå ¼ö¼úÀÇ Áõ°¡ µîÀÔ´Ï´Ù. ±×·¯³ª ½É¹æ¼¼µ¿ Áø´Ü ¹× Ä¡·á¿¡ µû¸¥ Ç÷Àü»öÀüÁõ À§Çè Áõ°¡, ½ÅÈï±¹ÀÇ ½É¹æ¼¼µ¿¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »õ·Î¿î ÀýÁ¦ ±â¼ú °³¹ßÀÇ ¿¬±¸°³¹ß°ú Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ½ºÅ¸Æ®¾÷ÀÇ ÃâÇöÀº ÇâÈÄ ¸î ³â µ¿¾È Å« ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
¼¼°è ½É¹æ¼¼µ¿ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀ» ȸ»ç ¼Ò°³, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, ÁÖ¿ä ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
ÁÖ¿ä ±â¾÷À¸·Î´Â Pfizer Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, AtriCure, Inc., Sanofi, Bayer AG, Gilead Sciences, Inc., Amgen Inc., Merck & Co., Inc., St. Jude Medical, Inc., Cardiovascular Systems, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
½É¹æ¼¼µ¿ ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ½É¹æ¼¼µ¿ ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ¹ßÀü
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å/½ÂÀÎ
PEST ºÐ¼®
PORTERÀÇ ºÐ¼®
ÀμöÇÕº´ ½Ã³ª¸®¿À
¾÷°è µ¿Çâ
Á¦4Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå, À¯Çüº°, 2020-2032³â
¹ßÀÛ¼º ½É¹æ¼¼µ¿
Áö¼Ó¼º ½É¹æ¼¼µ¿
¿µ¼Ó¼º ½É¹æ¼¼µ¿
Á¦5Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå, Ä¡·á¹ýº°, 2020-2032³â
Á¦6Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå, ±â¼úº°, 2020-2032³â
¹«¼±Á֯ļö
·¹ÀÌÀú
µ¿°á¿ä¹ý
±âŸ
Á¦7Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â
º´¿ø
½ÉÀå ¼¾ÅÍ
ȨÄÉ¾î ¼³Á¤
±âŸ
Á¦8Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå, Áö¿ªº°, 2020-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
秵¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
Pfizer Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Johnson & Johnson
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
AtriCure, Inc.
Sanofi
Bayer AG
Gilead Sciences, Inc.
Amgen Inc.
Merck & Co., Inc.
Jude Medical, Inc.
Cardiovascular Systems, Inc.
Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×
Wheel of Fortune
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Coherent Opportunity Map
Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý
Âü°í¹®Çå
Á¶»ç ¹æ¹ý
ÃâÆÇ»ç ¼Ò°³
ksm
¿µ¹® ¸ñÂ÷
Global Atrial Fibrillation Market is estimated to be valued at US$ 26.43 Bn in 2025 and is expected to reach US$ 43.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
US$ 26.43 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
7.40%
2032 Value Projection:
US$ 43.57 Bn
Figure. Atrial Fibrillation Market Share (%), By Region 2025
Atrial fibrillation is the most common cardiac arrhythmia globally and the prevalence of diagnosed cases is growing rapidly. Rising geriatric population, increasing incidence of cardiovascular & lifestyle diseases, growth in invasive cardiac procedures, and technological advancements in diagnostic and treatment devices are some of the key factors fueling the growth of this market. However, risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are expected to hamper market growth.
Market Dynamics:
The key drivers propelling the growth of global atrial fibrillation market are rapid growth in geriatric population who are more susceptible to atrial fibrillation, rising prevalence of obesity and hypertension, increasing consumption of alcohol and tobacco, and growing number of invasive cardiac surgeries. However, high risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are projected to hinder the market growth. Growing research on development of novel ablation technologies and emergence of start-up companies offering innovative solutions present significant opportunities in the coming years.
Key Features of the Study:
This report provides in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, AtriCure, Inc., Sanofi, Bayer AG, Gilead Sciences, Inc., Amgen Inc., Merck & Co., Inc., St. Jude Medical, Inc., and Cardiovascular Systems, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market
Market Segmentation
Type Insights (Revenue, USD Bn, 2020 - 2032)
Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Permanent Atrial Fibrillation
Treatment Insights (Revenue, USD Bn, 2020 - 2032)
Pharmacological Treatments
Anticoagulants
Antiarrhythmic Drugs
Non-Pharmacological Treatments
Catheter Ablation
Surgical Procedures
Implantable Devices
Technology Insights (Revenue, USD Bn, 2020 - 2032)
Radiofrequency
Laser
Cryotherapy
Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
Hospitals
Cardiac Centers
Home Care Settings
Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Pfizer Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Johnson & Johnson
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
AtriCure, Inc.
Sanofi
Bayer AG
Gilead Sciences, Inc.
Amgen Inc.
Merck & Co., Inc.
Jude Medical, Inc.
Cardiovascular Systems, Inc.
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Atrial Fibrillation Market, By Type
Global Atrial Fibrillation Market, By Treatment
Global Atrial Fibrillation Market, By Technology
Global Atrial Fibrillation Market, By End User
Global Atrial Fibrillation Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Atrial Fibrillation Market, By Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Paroxysmal Atrial Fibrillation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Persistent Atrial Fibrillation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Permanent Atrial Fibrillation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Atrial Fibrillation Market, By Treatment, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pharmacological Treatments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticoagulants
Antiarrhythmic Drugs
Non-Pharmacological Treatments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Catheter Ablation
Surgical Procedures
Implantable Devices
6. Global Atrial Fibrillation Market, By Technology, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Radiofrequency
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cryotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Atrial Fibrillation Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Atrial Fibrillation Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Latin America
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
9. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Boehringer Ingelheim GmbH
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Boston Scientific Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Medtronic plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AtriCure, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi
Bayer AG
Gilead Sciences, Inc.
Amgen Inc.
Merck & Co., Inc.
Jude Medical, Inc.
Cardiovascular Systems, Inc.
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us
°ü·ÃÀÚ·á